233 related articles for article (PubMed ID: 16327311)
1. Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C.
Racioppi M; Porreca A; Foschi N; Delicato G; Destito A; D'Addessi A
Urol Int; 2005; 75(4):373-5. PubMed ID: 16327311
[TBL] [Abstract][Full Text] [Related]
2. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
[TBL] [Abstract][Full Text] [Related]
3. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
Kalsi J; Harland SJ; Feneley MR
Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
[TBL] [Abstract][Full Text] [Related]
4. Intravesical mitomycin C for superficial transitional cell carcinoma.
Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
[TBL] [Abstract][Full Text] [Related]
5. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
6. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
7. Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.
Shapiro O; Jones K; Wang C; Landas S; Haas GP
Can J Urol; 2006 Dec; 13(6):3317-20. PubMed ID: 17187694
[TBL] [Abstract][Full Text] [Related]
8. [Intravesical instillation in the treatment of superficial tumors of the bladder].
Chopin DK
Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
[TBL] [Abstract][Full Text] [Related]
9. Histological changes due to intravesical instillation of mitomycin C.
Castillo OA; Landerer E; Feria-Flores M; Vidal-Mora I; Franco C
Arch Esp Urol; 2012 Jun; 65(5):578-82; discussion 582. PubMed ID: 22732786
[TBL] [Abstract][Full Text] [Related]
10. Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant!
Fazlioglu A; Tandogdu Z; Kurtulus FO; Parlakkilic O; Cek M
Urol Int; 2009; 83(3):362-3. PubMed ID: 19829042
[TBL] [Abstract][Full Text] [Related]
11. Incrusted cystitis after intravesical mitomycin C treatment.
Llopis M; Moreno J; Botella R; Algado M
Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682
[TBL] [Abstract][Full Text] [Related]
12. [Management of non invasive bladder cancers. T1Ga urothelial cell carcinoma: benefit of immediate post operative instillation?].
Rouprêt M; Guillotreau J; Irani J; Zerbib M
Prog Urol; 2010 Mar; 20 Suppl 1():S46-9. PubMed ID: 20493444
[TBL] [Abstract][Full Text] [Related]
13. Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study.
Di Stasi SM; Giannantoni A; Stephen RL; Capelli G; Navarra P; Massoud R; Vespasiani G
J Urol; 2003 Sep; 170(3):777-82. PubMed ID: 12913696
[TBL] [Abstract][Full Text] [Related]
14. [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder].
Cuervo Pinna MA; Cuervo Pinna C; Macías Castillo S; Bureo Dacal JC; Espada Alonso MJ; Pimentel Leo J
An Med Interna; 2001 Dec; 18(12):641-3. PubMed ID: 11852501
[TBL] [Abstract][Full Text] [Related]
15. [Bladder necrosis after an immediate post-operative mitomycin C instillation].
Branchereau J; Luyckx F; Hitier M; Karam G; Bouchot O; Rigaud J
Prog Urol; 2011 Feb; 21(2):151-3. PubMed ID: 21296285
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.
Solsona E; Iborra I; Ricós JV; Monrós JL; Casanova J; Dumont R
J Urol; 1999 Apr; 161(4):1120-3. PubMed ID: 10081851
[TBL] [Abstract][Full Text] [Related]
17. [Blood and tissue levels of mitomycin C after intravesical instillation].
Flüchter SH; Hlobil H; Harzmann R; Rothe KF; Bichler KH
Urol Int; 1983; 38(6):321-8. PubMed ID: 6419427
[TBL] [Abstract][Full Text] [Related]
18. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
[TBL] [Abstract][Full Text] [Related]
19. Endovesical instillation of mitomycin-C in preventing recurrence of superficial bladder carcinoma.
Wu JJ; Yin ZL; Zhu JN
Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1160-3. PubMed ID: 1514829
[TBL] [Abstract][Full Text] [Related]
20. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
